BioNexus & Fidelion Partner for Cancer Test
Update: 2025-11-12
Description
BioNexus Gene Lab Corporations stock surges as they partner with Fidelion Diagnostics to bring VitaGuard, a revolutionary blood test for minimal residual disease detection, to Southeast Asia. This share swap deal aligns interests and makes advanced cancer testing more accessible and affordable in the ASEAN region.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
